---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-000595"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T05:55:16.556447+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Shuttle Pharmaceuticals enters consulting deal with Bowery; $260K fee due after Nasdaq compliance regained

## Summary
- Six-month consulting agreement with Bowery Consulting Group effective March 21, 2025.
- Services include research, due diligence, partnership evaluation, and capital raising strategy.
- Total fee of $260,000, payable only after Shuttle regains full compliance with Nasdaq Listing Rules.
- Agreement aims to support reaching milestones and attract investors.

## SEC filing metadata
- accession: 0001641172-25-000595
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000164117225000595/0001641172-25-000595-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000164117225000595/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-000595
- JSON: https://secwatch.observer/filing/0001641172-25-000595.json
- Plain text: https://secwatch.observer/filing/0001641172-25-000595.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.